Citation Impact
Citing Papers
Guidelines for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack
2014 Standout
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease
2014 Standout
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease
2014 Standout
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: Executive Summary
2014 Standout
Skin cancer in organ transplant recipients: Epidemiology, pathogenesis, and management
2002
Regulatory T-cell directed therapies in liver diseases
2013 StandoutNobel
Microbiological Hazards Related to Xenotransplantation of Porcine Organs Into Man
2009
Immune activation is required for the induction of liver allograft tolerance: Implications for immunosuppressive therapy
2001
Cyclosporine and tacrolimus (FK506): A comparison of efficacy and safety profiles
1999
Chimerism of the Transplanted Heart
2002 Standout
Transplantation tolerance from a historical perspective
2001
Immunosuppressive drug monitoring - what to use in clinical practice today to improve renal graft outcome
2005
Guidelines for the use of immunosuppressive drugs in patients with ocular inflammatory disorders: recommendations of an expert panel
2000 Standout
The Presence of Foxp3 Expressing T Cells Within Grafts of Tolerant Human Liver Transplant Recipients
2008 StandoutNobel
Complete weaning off immunosuppression in HCV liver transplant recipients is feasible and favourably impacts on the progression of disease recurrence
2006
Tacrolimus is superior to cyclosporine in liver transplantation
1998
Guidelines for the use of an insulin infusion for the management of hyperglycemia in critically ill patients
2012 Standout
Immunosuppressive Drugs in Paediatric Liver Transplantation
2001
Predictive factors for early mortality following liver transplantation
2003
Calcineurin Inhibitor Nephrotoxicity
2009 Standout
Role of Antioxidants and Natural Products in Inflammation
2016 Standout
WEANING OF IMMUNOSUPPRESSION IN LIVING DONOR LIVER TRANSPLANT RECIPIENTS1
2001
Long‐term effects of pancreatic transplantation on diabetic neuropathy
1997
Transplantation in Parkinson’s Disease
2007
Low circulating regulatory T-cell levels after acute rejection in liver transplantation
2006
High-Dose/Activation-Associated Tolerance
1997
Mechanisms of Clinically Relevant Drug Interactions Associated with Tacrolimus
2002
Portal hypertension and variceal bleeding: An AASLD single topic symposium†
1998
Impact of donor infections on outcome of orthotopic liver transplantation
2003
Post-Transplant Diabetes Mellitus The Role of Immunosuppression
1997
Implication of advanced donor age on the outcome of liver transplantation
2000
Steroid-free Immunosuppression in Kidney Transplantation: An Editorial Review
2002
Estimation of failure probabilities in the presence of competing risks: new representations of old estimators
1999 Standout
PREGNANCY AFTER LIVER TRANSPLANTATION UNDER TACROLIMUS1
1997
Diagnosis and Management of Autoimmune Hepatitis
2010
Therapeutic drug monitoring of immunosuppressant drugs in clinical practice
2002
Analyses of Peripheral Blood Mononuclear Cells in Operational Tolerance After Pediatric Living Donor Liver Transplantation
2004 StandoutNobel
Characteristics Associated with Liver Graft Failure: The Concept of a Donor Risk Index
2006 Standout
A 10-Year Experience of Liver Transplantation for Hepatitis C: Analysis of Factors Determining Outcome in Over 500 Patients
2001
Expanding consensus in portal hypertension
2015 Standout
Parkinson's disease
2009 Standout
Diagnosis, management, and treatment of hepatitis C: An update # † ‡
2008 Standout
Effect of macrovescicular steatosis and other donor and recipient characteristics on the outcome of liver transplantation
2001
Skin Cancers after Organ Transplantation
2003 Standout
Management of Hepatocellular Carcinoma *
2005 Standout
Requirement of Protocol Biopsy Before and After Complete Cessation of Immunosuppression After Liver Transplantation
2009 StandoutNobel
WEANING OF IMMUNOSUPPRESSION IN LIVER TRANSPLANT RECIPIENTS12
1997
Tacrolimus (FK506) and methotrexate as prophylaxis for acute graft-versus-host disease in pediatric allogeneic stem cell transplantation
2000
Anticoagulant-related bleeding: Clinical epidemiology, prediction, and prevention
1993 Standout
Diabetes Mellitus after Kidney Transplantation in the United States
2003 Standout
Use of Neoral C2 monitoring: a European consensus
2005
Should hepatomas be treated with hepatic resection or transplantation?
1999
Clinical Pharmacokinetics and Pharmacodynamics of Tacrolimus in Solid Organ Transplantation
2004 Standout
Clinical Pharmacokinetics of Tacrolimus
1995 Standout
Transplantation Tolerance, Microchimerism, and the Two-Way Paradigm
1998
Inhibition of T–Cell Responses by Hepatic Stellate Cells Via B7–H1-Mediated T–Cell Apoptosis in Mice
2004
Dendritic Cell Subset Ratio in Peripheral Blood Correlates with Successful Withdrawal of Immunosuppression in Liver Transplant Patients
2003
Regulatory T cells in transplantation tolerance
2003 StandoutNobel
Evaluation of Renal Function in Liver Transplant Recipients Receiving Daclizumab (Zenapax), Mycophenolate Mofetil, and a Delayed, Low-Dose Tacrolimus Regimen Vs. a Standard-Dose Tacrolimus and Mycophenolate Mofetil Regimen
2005
Clinical benefits of neoral C2 monitoring in the long-term management of renal transplant recipients1
2003
Tacrolimus
1997
Hyponatremia and Mortality among Patients on the Liver-Transplant Waiting List
2008 Standout
Strategies to Improve Long-Term Outcomes after Renal Transplantation
2002 Standout
Ethical sourcing of human embryonic stem cells — rational solutions?
2005 StandoutNobel
Clinical Trials of Transplant Tolerance: Slow But Steady Progress
2003
Defining the outcome of immunosuppression withdrawal after liver transplantation
1998
The cellular actions of digitalis glycosides on the heart
1994
High-mobility group box 1 protein (HMGB1): nuclear weapon in the immune arsenal
2005 Standout
Cholangiocarcinoma
2007 Standout
The Next Frontier of Regulatory T Cells: Promising Immunotherapy for Autoimmune Diseases and Organ Transplantations
2020
SAFETY AND EFFICACY OF TACROLIMUS IN COMBINATION WITH MYCOPHENOLATE MOFETIL (MMF) IN CADAVERIC RENAL TRANSPLANT RECIPIENTS1
2000
Hepatic Resection and Transplantation for Peripheral Cholangiocarcinoma
1997
Infection in Solid-Organ Transplant Recipients
2007 Standout
The Use of Therapeutic Drug Monitoring to Optimise Immunosuppressive Therapy
1996
Immunosuppressive Drugs for Kidney Transplantation
2004 Standout
Opportunities for Treg cell therapy for the treatment of human disease
2023 StandoutNobel
HLA-Mismatched Renal Transplantation without Maintenance Immunosuppression
2008 Standout
Tacrolimus in solid organ transplantation: an update
1999
Hemorrhagic Complications of Anticoagulant Treatment
2001 Standout
The therapeutic potential of carbon monoxide
2010 Standout
Therapeutic drug monitoring of tacrolimus in pediatric liver transplant patients
2001
Hepatic Stellate Cells: Protean, Multifunctional, and Enigmatic Cells of the Liver
2008 Standout
Retinoids for the Management of Dermatological Complications of Organ Transplantation
1997
Advances in the Diagnosis, Pathogenesis, and Management of Autoimmune Hepatitis
2010
Tacrolimus versus microemulsified ciclosporin in liver transplantation: the TMC randomised controlled trial
2002
High-Performance Liquid Chromatography-Tandem Mass Spectrometry as a Reference for Analysis of Tacrolimus to Assess Two Immunoassays in Patients With Liver and Renal Transplants
1997
Revising consensus in portal hypertension: Report of the Baveno V consensus workshop on methodology of diagnosis and therapy in portal hypertension
2010 Standout
Pretransplant MELD Score As a Predictor of Outcome After Liver Transplantation for Chronic Hepatitis C
2003
Long‐term outcomes in pediatric liver recipients: Comparison between cyclosporin A and tacrolimus
1999
Utilization of a Computerized Intravenous Insulin Infusion Program to Control Blood Glucose in the Intensive Care Unit
2007
DOUBLE BLIND TRIAL OF LONG‐TERM ANTICOAGULANT TREATMENT AFTER MYOCARDIAL INFARCTION
1969
Biliary complications in pediatric living related liver transplantation
1998 StandoutNobel
Two-year data from the European multicentre tacrolimus (F 06) liver study
1996
The role of the graft in establishing tolerance
2002
Inhalation of carbon monoxide prevents liver injury and inflammation following hind limb ischemia/reperfusion
2004
Tacrolimus
2000
THE EVOLUTION OF IMMUNOSUPPRESSION WITH FK506 IN PEDIATRIC LIVING-RELATED LIVER TRANSPLANTATION1
1996
FK506 in combination with methotrexate for the prevention of graft- versus-host disease after marrow transplantation from matched unrelated donors
1996
Decreased skin cancer after cessation of therapy with transplant-associated immunosuppressants.
2001
Special Issue: KDIGO Clinical Practice Guideline for the Care of Kidney Transplant Recipients
2009 Standout
Target of rapamycin inhibitors (TOR-I; sirolimus and everolimus) for primary immunosuppression in kidney transplant recipients
2006
Guidelines for Prevention of Stroke in Patients With Ischemic Stroke or Transient Ischemic Attack
2006 Standout
Chronic rejection. A general overview of histopathology and pathophysiology with emphasis on liver, heart and intestinal allografts.
1997
The Clinical Benefits of Cyclosporine C2-Level Monitoring: A Systematic Review
2007
Standardization of Uveitis Nomenclature for Reporting Clinical Data. Results of the First International Workshop
2005 Standout
2007 Guideline for Isolation Precautions: Preventing Transmission of Infectious Agents in Health Care Settings
2007 Standout
2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines
2020 Standout
Hepatitis C and liver transplantation
2001
Systemic Embolism and Anticoagulant Prophylaxis in Rheumatic Heart Disease
1964
Diabetic Somatic Neuropathies
2004 Standout
Cutting Edge: Chronic Inflammatory Liver Disease in Mice Expressing a CD28-Specific Ligand
2012 StandoutNobel
Guidelines for the Prevention of Stroke in Patients With Stroke or Transient Ischemic Attack
2010 Standout
Sodium/Calcium Exchange: Its Physiological Implications
1999 Standout
Autoimmune hepatitis: new paradigms in the pathogenesis, diagnosis, and management
2010
Works of John McMichael being referenced
SCREENING DONORS FOR XENOTRANSPLANTATION
1994
Tacrolimus for Rescue of Refractory Renal Allograft Rejection
1998
Hepatic Dysfunction Increases Length of Stay and Risk of Death after Injury
2002
Liver Transplantation Under Tacrolimus In Infants, Children, Adults, and Seniors: Long-Term Results, Survival, and Adverse Events in 1000 Consecutive Patients
1998
Clinical outcome of patients infected with hepatitis C virus infection on survival after primary liver transplantation under tacrolimus
1998
Weaning Of Immunosuppression In Long-Term Liver Transplant Recipients
1995
STIMULATED RESPONSE OF PERIPHERAL LYMPHOCYTES MAY DISTINGUISH CYCLOSPORINE EFFECT IN RENAL TRANSPLANT RECIPIENTS RECEIVING A CYCLOSPORINE+RAPAMYCIN REGIMEN1
2000
Outcome After Steroid Withdrawal in Renal Transplant Patients Receiving Tacrolimus-Based Immunosuppression
1998
Randomised trialomania? The multicentre liver transplant trials of tacrolimus
1995
Computer-Guided Concentration-Controlled Trials in Autoimmune Disorders
1993
A PROSPECTIVE RANDOMIZED TRIAL OF TACROLIMUS AND PREDNISONE VERSUS TACROLIMUS, PREDNISONE, AND MYCOPHENOLATE MOFETIL IN PRIMARY ADULT LIVER TRANSPLANT RECIPIENTS
1998
Management of Insulin Therapy in Urban Diabetes Patients Is Facilitated by Use of an Intelligent Dosing System
2004
Three dimensional surface mapping and simulation of FK506 dose-level relationships
1993
ANTICOAGULANT THERAPY
1961
The Pittsburgh randomized trial of tacrolimus compared to cyclosporine for hepatic transplantation.
1996
Tacrolimus: a potential new treatment for autoimmune chronic active hepatitis: results of an open-label preliminary trial.
1995
Digitalis in the last half century.
1982
Weaning Of Immunosuppression In Long-Term Liver Transplant Recipients
1995
Effect of donor age and sex on the outcome of liver transplantation
1995